Sept. 14, 2022, 1:11 a.m. | Kehan Wu, Yingce Xia, Yang Fan, Pan Deng, Haiguang Liu, Lijun Wu, Shufang Xie, Tong Wang, Tao Qin, Tie-Yan Liu

cs.LG updates on arXiv.org arxiv.org

Structure-based drug design is drawing growing attentions in computer-aided
drug discovery. Compared with the virtual screening approach where a
pre-defined library of compounds are computationally screened, de novo drug
design based on the structure of a target protein can provide novel drug
candidates. In this paper, we present a generative solution named TamGent
(Target-aware molecule generator with Transformer) that can directly generate
candidate drugs from scratch for a given target, overcoming the limits imposed
by existing compound libraries. Following the …

arxiv bio design drug design molecules protein solution transformer

Software Engineer for AI Training Data (School Specific)

@ G2i Inc | Remote

Software Engineer for AI Training Data (Python)

@ G2i Inc | Remote

Software Engineer for AI Training Data (Tier 2)

@ G2i Inc | Remote

Data Engineer

@ Lemon.io | Remote: Europe, LATAM, Canada, UK, Asia, Oceania

Artificial Intelligence – Bioinformatic Expert

@ University of Texas Medical Branch | Galveston, TX

Lead Developer (AI)

@ Cere Network | San Francisco, US